GRIFOLS | GRF - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Alcon AG USD 21.6B 538M 2026-06
Almirall EUR 1.53B 43.26M 2026-06
Amadeus IT EUR 4.99B 411.3M 2026-09
Amarin USD 444.41M 796K 2026-09
argenx SE USD 8.42B 1.09B 2026-06
AstraZeneca USD 51.73B 1.43B 2026-09
Bayer EUR 29.18B 533M 2026-09
Cie Automotive EUR 1.45B 46.93M 2025-12
Demant DKK 11.24B 1.4B 2026-06
Ence Energia y Celulosa EUR 548.9M 3.7M 2026-09
Essilor EUR 39.22B 329M 2026-06
Ferrovial EUR 7.4B 269M 2026-06
Fresenius EUR 20.51B 810M 2026-09
Fresenius Medical Care EUR 13.76B 226.23M 2026-09
Genmab DKK 5.96B 275M 2026-06
GlaxoSmithKline GBP 18.75B 1.11B 2026-09
GRIFOLS EUR 5.79B 2.19B 2026-09
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Inditex 18.99B 193M 2026-03
Lakefront Biotherapeutics EUR 3.26B 10.26M 2026-06
Merck EUR 31.34B 1.16B 2026-09
Novartis USD 37.23B 4.72B 2026-09
Philips EUR 11.61B 133M 2026-09
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 72.88B 3.31B 2026-09
Smith & Nephew USD 5.18B 356M 2026-06
UCB EUR 10.87B 1.18B 2025-12
Viscofan EUR 1.01B 94.56M 2026-09